# Howard Goodwin

> Howard Goodwin is a Series A investor at Intrinsic Capital Partners backing Biotechnology. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Intrinsic Capital Partners](https://shizune.co/investors/profile/intrinsic-capital-partners)
- Location: Greater Philadelphia Area, United States
- Total investments: 4
- Last investment: Feb 2023
- Lead investor: 75%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/howard-goodwin-bb7b8735/

Howard Goodwin is a Series A investor at Intrinsic Capital Partners in Greater Philadelphia Area focused on Biotechnology and Health Care. Howard Goodwin is the Partner and Founder of Intrinsic Capital Partners. Howard Goodwin attended the Thomas Jefferson University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 3 | 75% |
| Health Care | 2 | 50% |
| Cannabis | 1 | 25% |
| Chemical | 1 | 25% |
| Biopharma | 1 | 25% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 50% |
| Series D | 1 | 25% |
| Venture - Series Unknown | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Nalu Bio | Nalu Bio is a biotech company developing CBD (and cannabinoids) through chemistry (not plants), for companies who want pure and safe ingredients that are better for the planet. Ranked as the #1 CBD producer on the “google for ingredients.” Like plant-based meats, Nalu Bio will fundamentally disrupt CBD production with chemistry. Nalu Bio uses 700xless land, 70x less water, and 14x less energy to produce its cannabinoids while ensuring best-in-class purity and quality (0% THC, no chemicals, no pesticides) without the high capital investment costs of hemp extraction and biosynthesis. | $12M | Series A | Feb 28, 2023 |  |
| Biopharmaceutical Research Company | Biopharmaceutical Research Company develops active pharmaceutical ingredients for plant therapeutics. The company focuses on the production of cannabis for researchers across the United States and the USDA-compliant THC testing of hemp. | $20M | Series A | Oct 04, 2022 |  |
| Hound Labs | Hound Labs is a breath technology company that has developed ultra-sensitive technology for non-invasive breath measurement. Utilizing this groundbreaking technology, the HOUND MARIJUANA BREATHALYZER is the world’s first breathalyzer to rapidly, accurately, and inexpensively measure recent marijuana use and alcohol in a person’s breath. The HOUNDBREATHALYZER is intended for law enforcement, employer, and insurance purposes only. Founded in 2014, the Oakland-based company was created by Dr. Mike Lynn, an ER physician, reserve deputy sheriff, and former venture capitalist, his co-founder, Mr. Kuni Oh, a patent attorney with a deep background in engineering and science, and his co-founder, Ms. Jenny Lynn, a business executive with twenty years of experience launching new ventures. Benchmark, Icon Ventures, Intrinsic Capital Partners, Main Street Advisors, NFP Ventures, and individual investors have funded the Company. | $20M | Venture - Series Unknown | Sep 03, 2021 |  |
| Hound Labs | Hound Labs is a breath technology company that has developed ultra-sensitive technology for non-invasive breath measurement. Utilizing this groundbreaking technology, the HOUND MARIJUANA BREATHALYZER is the world’s first breathalyzer to rapidly, accurately, and inexpensively measure recent marijuana use and alcohol in a person’s breath. The HOUNDBREATHALYZER is intended for law enforcement, employer, and insurance purposes only. Founded in 2014, the Oakland-based company was created by Dr. Mike Lynn, an ER physician, reserve deputy sheriff, and former venture capitalist, his co-founder, Mr. Kuni Oh, a patent attorney with a deep background in engineering and science, and his co-founder, Ms. Jenny Lynn, a business executive with twenty years of experience launching new ventures. Benchmark, Icon Ventures, Intrinsic Capital Partners, Main Street Advisors, NFP Ventures, and individual investors have funded the Company. | $30M | Series D | Aug 27, 2019 |  |

4 of 4 investments shown.

## Co-investors
- [Icon Ventures](https://shizune.co/investors/profile/iconventures) — VC Fund, 2 deals together
- [Achari Ventures](https://shizune.co/investors/profile/achari-ventures) — VC Fund, 1 deal together
- [AFI Capital Partners](https://shizune.co/investors/profile/afi-capital-partners) — VC Fund, 1 deal together
- [Argonautic Ventures](https://shizune.co/investors/profile/argonautic-ventures) — VC Fund, 1 deal together
- [Axial VC](https://shizune.co/investors/profile/axial-vc) — VC Fund, 1 deal together
- [Benchmark](https://shizune.co/investors/profile/benchmark) — VC Fund, 1 deal together

## About Intrinsic Capital Partners

VC Fund · Philadelphia, United States

Intrinsic Capital Partners is a private equity fund dedicated to investing in promising growth businesses in the emerging legal cannabis industry. Their team has years of investment, pharmaceutical, regulatory, and deal structure experience. Along with our world class network of operating partners with decades of experience building businesses andbrands across healthcare and consumer industries, they are dedicated to creating value for portfolio company owners while generating superior returns for our fund investors.

3 contacts available at Intrinsic Capital Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Cornelius Merlini | Managing Partner & Founder | https://shizune.co/investors/profile/cornelius-merlini-3d92 |
| Gerald F Stahlecker | Partner & Founder | https://shizune.co/investors/profile/gerald-f-stahlecker |
| Howard Goodwin | Partner & Founder | https://shizune.co/investors/profile/howard-goodwin |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Howard Goodwin invest in?

Howard Goodwin invests primarily in Biotechnology, Health Care and Cannabis startups, most often at Series A and Series D stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Howard Goodwin last invest?

The most recent investment recorded for Howard Goodwin closed in Feb 2023. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co